<DOC>
	<DOCNO>NCT00139334</DOCNO>
	<brief_summary>The main objective study provide immunogenicity data GSK Biologicals ' HRV vaccine co-administered OPV give alone ( HRV vaccine dose give 15 day OPV dose ) .</brief_summary>
	<brief_title>A Study Test 2 Doses HRV Vaccine Given With Without OPV Healthy Infants Bangladesh</brief_title>
	<detailed_description>`` The study four group : Group HRV + OPV , Group HRV alone , Group Placebo + OPV Group Placebo alone . Two-dose immunisation administer healthy infant approximately 12 16 week age . Immunogenicity , reactogenicity safety relative placebo also evaluate . Treatment allocation : randomize ( 2:2:1:1 ) . Routine EPI vaccine administer study follow EPI recommendation Bangladesh . ''</detailed_description>
	<mesh_term>Rotavirus Infections</mesh_term>
	<criteria>Inclusion criterion : Healthy infant age 6 weeksÂ±1 first study vaccination . Exclusion criterion : Malnutrition , history rotavirus gastroenteritis , allergic disease chronic gastrointestinal disease , receive protocolprohibited treatment .</criteria>
	<gender>All</gender>
	<minimum_age>5 Weeks</minimum_age>
	<maximum_age>7 Weeks</maximum_age>
	<verification_date>September 2016</verification_date>
</DOC>